Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Christoph Oing.

Newcastle AuthorsTitleYearFull text
Professor Alastair Greystoke
Professor Ruth Plummer
Dr Christoph Oing
Dr Pasquale Rescigno
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis2024
Dr Christoph Oing
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis2024
Dr Christoph Oing
Dr Pasquale Rescigno
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review2024
Dr Christoph Oing
Dr Pasquale Rescigno
Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour2024
Sarah Rae
Ellie Taylor
Joseph Hoben
Dr Christoph Oing
Professor Alastair Greystoke
et al.		Social determinants of health inequalities in early phase clinical trials in Northern England2024
Dr Christoph Oing
Career and Professional Development for Young Oncologists2023
Dr Christoph Oing
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty2023
Dr Christoph Oing
European Association of Urology Guidelines on Testicular Cancer: 2023 Update2023
Dr Christoph Oing
Dr Pasquale Rescigno
Genomic tests for persistence PSA after radical prostatectomy: smoke and mirrors or new effective tools for the clinical decision-making?2023
Dr Christoph Oing
Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease2023
Dr Christoph Oing
Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy2023
Dr Christoph Oing
Testicular Tumors High Likelihood of Cure With Interdisciplinary Management2023
Dr Christoph Oing
Therapy monitoring of neoadjuvant chemo-/radiotherapy [Therapiemonitoring der neoadjuvanten Radio‑/Chemotherapie]2023
Dr Christoph Oing
Young oncologists’ perspective on the role and future of the clinician-scientist in oncology2023
Dr Christoph Oing
28/m with back pain and bulging of the abdominal wall: Preparation for the medical specialist examination: part 1 [28/m mit Rückenschmerzen und Vorwölbung der Bauchwand: Vorbereitung auf die Facharztprüfung: Fall 1]2022
Dr Christoph Oing
Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients2022
Dr Christoph Oing
Chromosome 3p25.3 Gain Is Associated with Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors2022
Dr Christoph Oing
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group2022
Dr Christoph Oing
Medical specialist training internal medicine and Hematology and oncology: The second special issue is here! [Facharzt-Training Innere Medizin und Hämatologie und Onkologie: Das zweite Sonderheft ist da!]2022
Dr Christoph Oing
Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative Review2022
Dr Christoph Oing
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy2022
Dr Christoph Oing
Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry2022
Dr Christoph Oing
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review2022
Dr Christoph Oing
Testicular tumours from a clinical point of view: What urologists and oncologists need to know from the pathologist about testicular cancer [Hodentumoren aus klinischer Sicht: Was Urolog:Innen und Onkolog:Innen von Patholog: Innen über Hodentumoren wissen müssen]2022
Dr Christoph Oing
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series2022
Dr Christoph Oing
Therapy of clinical stage IIA and IIB seminoma: a systematic review2022